Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Abivax S.A.
Next earnings Sep 21, 2026 · consensus $-1.83 EPS, $2.55M rev
Mixed signals in the latest filings.
Abivax S.A. shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001956827, latest 6-K filed 2026-06-02) · EODHD · as of 6/23/2026, 1:43:19 AM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
€15/mo · cancel anytime
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1482 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.